Cargando…

Appropriateness of administration of nasogastric medication and preliminary intervention

A utilization study was performed in a 2200-bed tertiary care teaching hospital. Data mining was performed on all nasogastric medication prescriptions for patients hospitalized in 2011. Nurses were interviewed by questionnaire. A PDCA (Plan-Do-Check-Act) cycle was used for continuous quality improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ling-Ling, Xu, Ling-Cheng, Wang, Hui-Qin, Jin, Jing-Fen, Wang, Hua-Fen, Zhou, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506154/
https://www.ncbi.nlm.nih.gov/pubmed/23185120
http://dx.doi.org/10.2147/TCRM.S37785
_version_ 1782250865648730112
author Zhu, Ling-Ling
Xu, Ling-Cheng
Wang, Hui-Qin
Jin, Jing-Fen
Wang, Hua-Fen
Zhou, Quan
author_facet Zhu, Ling-Ling
Xu, Ling-Cheng
Wang, Hui-Qin
Jin, Jing-Fen
Wang, Hua-Fen
Zhou, Quan
author_sort Zhu, Ling-Ling
collection PubMed
description A utilization study was performed in a 2200-bed tertiary care teaching hospital. Data mining was performed on all nasogastric medication prescriptions for patients hospitalized in 2011. Nurses were interviewed by questionnaire. A PDCA (Plan-Do-Check-Act) cycle was used for continuous quality improvement. The proportion of patients with nasogastric tubes (NGT) was 3.2%. A large number of medical orders (n = 6261) involved nasogastric medications with a package insert particularly noting that they should not be crushed or opened (group 1) or medications without a specific formulation recommendation in the package insert but having evidence discouraging NGT dosing (group 2). Of the nasogastrically administered sustained-release or controlled-release formulations, a sustained-release sodium valproate tablet formulation was the most prescribed drug and a sustained-release 2.5 mg felodipine tablet was prescribed with the highest proportion of NGT dosing [NGT/(NGT + oral) = 12.3%]. Among the nasogastrically administered enteric-coated formulations, a myrtol-standardized enteric-coated capsule formulation was the most prescribed drug and a pantoprazole tablet formulation was prescribed with the highest proportion of NGT dosing [NGT/(NGT + oral) = 19.3%]. Proportions of NGT dosing for amiodarone and carbamazepine (group 2) were 4.8% and 6.3%, respectively. The percentage of nurses with adequate knowledge about pharmaceutical dosage formulations was 60%. The rate of answering correctly as to whether medications in group 1 could be crushed or opened was only 30%. Awareness of evidence discouraging NGT dosing of medications in group 2 was zero. Most nurses (90%) left physicians and pharmacists with the entire responsibility for knowledge and decision-making concerning route of drug administration. After a 3-month preliminary intervention, irrational medical orders involving nasogastric administration of medications in group 1 were successfully abolished. The rate of answering correctly as to whether medications in group 1 could be crushed or opened increased to 100%. This utilization study indicates poor awareness concerning nasogastric administration of medication on the part of physicians and nurses, and preliminary intervention measures were efficient in improving knowledge through team cooperation and effort.
format Online
Article
Text
id pubmed-3506154
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-35061542012-11-26 Appropriateness of administration of nasogastric medication and preliminary intervention Zhu, Ling-Ling Xu, Ling-Cheng Wang, Hui-Qin Jin, Jing-Fen Wang, Hua-Fen Zhou, Quan Ther Clin Risk Manag Short Report A utilization study was performed in a 2200-bed tertiary care teaching hospital. Data mining was performed on all nasogastric medication prescriptions for patients hospitalized in 2011. Nurses were interviewed by questionnaire. A PDCA (Plan-Do-Check-Act) cycle was used for continuous quality improvement. The proportion of patients with nasogastric tubes (NGT) was 3.2%. A large number of medical orders (n = 6261) involved nasogastric medications with a package insert particularly noting that they should not be crushed or opened (group 1) or medications without a specific formulation recommendation in the package insert but having evidence discouraging NGT dosing (group 2). Of the nasogastrically administered sustained-release or controlled-release formulations, a sustained-release sodium valproate tablet formulation was the most prescribed drug and a sustained-release 2.5 mg felodipine tablet was prescribed with the highest proportion of NGT dosing [NGT/(NGT + oral) = 12.3%]. Among the nasogastrically administered enteric-coated formulations, a myrtol-standardized enteric-coated capsule formulation was the most prescribed drug and a pantoprazole tablet formulation was prescribed with the highest proportion of NGT dosing [NGT/(NGT + oral) = 19.3%]. Proportions of NGT dosing for amiodarone and carbamazepine (group 2) were 4.8% and 6.3%, respectively. The percentage of nurses with adequate knowledge about pharmaceutical dosage formulations was 60%. The rate of answering correctly as to whether medications in group 1 could be crushed or opened was only 30%. Awareness of evidence discouraging NGT dosing of medications in group 2 was zero. Most nurses (90%) left physicians and pharmacists with the entire responsibility for knowledge and decision-making concerning route of drug administration. After a 3-month preliminary intervention, irrational medical orders involving nasogastric administration of medications in group 1 were successfully abolished. The rate of answering correctly as to whether medications in group 1 could be crushed or opened increased to 100%. This utilization study indicates poor awareness concerning nasogastric administration of medication on the part of physicians and nurses, and preliminary intervention measures were efficient in improving knowledge through team cooperation and effort. Dove Medical Press 2012 2012-11-20 /pmc/articles/PMC3506154/ /pubmed/23185120 http://dx.doi.org/10.2147/TCRM.S37785 Text en © 2012 Zhu et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Short Report
Zhu, Ling-Ling
Xu, Ling-Cheng
Wang, Hui-Qin
Jin, Jing-Fen
Wang, Hua-Fen
Zhou, Quan
Appropriateness of administration of nasogastric medication and preliminary intervention
title Appropriateness of administration of nasogastric medication and preliminary intervention
title_full Appropriateness of administration of nasogastric medication and preliminary intervention
title_fullStr Appropriateness of administration of nasogastric medication and preliminary intervention
title_full_unstemmed Appropriateness of administration of nasogastric medication and preliminary intervention
title_short Appropriateness of administration of nasogastric medication and preliminary intervention
title_sort appropriateness of administration of nasogastric medication and preliminary intervention
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506154/
https://www.ncbi.nlm.nih.gov/pubmed/23185120
http://dx.doi.org/10.2147/TCRM.S37785
work_keys_str_mv AT zhulingling appropriatenessofadministrationofnasogastricmedicationandpreliminaryintervention
AT xulingcheng appropriatenessofadministrationofnasogastricmedicationandpreliminaryintervention
AT wanghuiqin appropriatenessofadministrationofnasogastricmedicationandpreliminaryintervention
AT jinjingfen appropriatenessofadministrationofnasogastricmedicationandpreliminaryintervention
AT wanghuafen appropriatenessofadministrationofnasogastricmedicationandpreliminaryintervention
AT zhouquan appropriatenessofadministrationofnasogastricmedicationandpreliminaryintervention